Cross-study projections of genomic biomarkers: An evaluation in cancer genomics

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Lucas, Joseph E ^a   Carvalho, Carlos M ^b   Chen, Julia Ling Yu ^a   Chi, Jen Tsan ^a   West, Mike ^c  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER GENETICS; CANCER RESISTANCE; CONTROLLED STUDY; DRUG RESPONSE; GENE EXPRESSION; GENETIC MARKER; GENOMICS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; PREDICTION; QUANTITATIVE ANALYSIS;

EID: 84887212455     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004523     Document Type: Article

References (39)

1. Nevins JR, Huang ES, Dressman H, Pittman J, Huang AT, et al. (2003) Towards integrated clinico-genomic models for personalized medicine: Combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet 12: 153-157.
2. Pittman J, Huang E, Dressman H, Horng C, Cheng S, et al. (2004) Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc Natl Acad Sci U S A 101: 8431-8436.
3. Spang R, Zuzan H, West M, Nevins J, Blanchette C, et al. (2001) Prediction and uncertainty in the analysis of gene expression profiles. In Silico Biol 2: Available http://www.bioinfo.de/isb/ via the internet.
4. West M, Blanchette C, Dressman H, Huang E, Ishida S, et al. (2001) Predicting the clinical status of human breast cancer utilizing gene expression profiles. Proc Natl Acad Sci U S A 98: 11462-11467.
5. Huang E, West M, Nevins JR (2002) Gene expression profiles and predicting clinical characteristics of breast cancer. Horm Res 58: 55-73.
6. Huang E, Chen S, Dressman H, Pittman J, Tsou MH, et al. (2003) Gene expression predictors of breast cancer outcomes. Lancet 361: 1590-1596.
7. Rich J, Jones B, Hans C, McClendon R, Bigner D, et al. (2005) Gene expression profiling and graphical genetic markers glioblastoma survival. Cancer Res 65: 4051-4058.
8. Chen JL, Lucas JE, Schroeder T, Mori S, Wu J, et al. (2008) The Genomic analysis of response to lactic acidosis in human cancers. PLoS Genet 4(12): e1000293.
9. Huang E, West M, Nevins J (2003) Gene expression phenotypes of oncogenic pathways. Cell Cycle 2: 415-417.
10. Huang E, Ishida S, Pittman J, Dressman H, Bild A, et al. (2003) Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet 34: 226-230.
11. Bild A, Yao G, Chang J, Wang Q, Potti A, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 53-357.
12. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929-1935.
13. Tomlins S, Mehra R, Rhodes D, Cao X, Wang L, et al. (2006) Integrative molecular concept modeling of prostate cancer progression. Nat Genet 39: 41-51.
14. Segal E, Friedman N, Koller D, Regev A (2004) A module map showing conditional activity of expression modules in cancer. Nat Genet 36: 1090-1098.
15. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
16. West M (2003) Bayesian factor regression models in the "large p, small n" paradigm. Bayesian Statistics 7: 723-732.
17. Carvalho C, Chang J, Lucas J, Nevins JR, Wang Q, et al. (2008) High-dimensional sparse factor modelling: Applications in gene expression genomics. J Am Stat Assoc, In Press.
18. Kumar L, Futschik ME (2007) "Mfuzz: A software package for soft clustering of microarray data". Bioinformation 2: 5-7.
19. MacQueen JB (1967) Some methods for classification and analysis of multivariate observations. In: Proceedings of fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley: University of California Press. pp 281-297.
20. Wang Q, Carvalho C, Lucas JE, West M (2007) Bfrm: Bayesian factor regression modelling. Bulletin of the International Society for Bayesian Analysis 14: 4-5. Available: http://xpress.isds.duke.edu:8080/bfrm/ via the internet.
21. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102: 13550-13555.
22. Hans C, Dobra A, West M (2007) Shotgun stochastic search in regression with many predictors. J Am Stat Assoc 102: 507-516.
23. Hans C, Wang Q, Dobra A, West M (2007) Sss: High-dimensional bayesian regression model search. Bulletin of the International Society for Bayesian Analysis 24: 8-9. Available: http://xpress.isds.duke.edu:8080/ sss/via the internet.
24. Raftery AE, Madigan D, Hoeting JA (1997) Bayesian model averaging for linear regression models. J Am Stat Assoc 92: 179-191.
25. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
26. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98: 262-272.
27. Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
28. Pawitan Y, Bjöhle J, Amler L, Borg A, Egyhazi S, et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7: R953-R964.
29. Chang JT, Nevins JR (2006) Gather: a systems approach to interpreting genomic signatures. Bioinformatics 22: 2926-2933.
30. Schlag P, Veser J, Geier G, Breitig D (1980) The influence of estradiol and adriamycin on the rna biosynthesis in breast cancer. J Cancer Res Clin Oncol 97: 63-70.
31. Lucas JE, Carvalho C, Wang Q, Bild A, Nevins J, et al. (2006) Sparse statistical modelling in gene expression genomics. In: Do KA, Muller P, Vannucci M, eds. Bayesian Inference for Gene Expression and Proteomics Cambridge University Press. pp 155-176.
32. Stock JL, Coderre JA, Burke EM, Danner DB, Chipman SD, et al. (1992) Identification of estrogen receptor mrna and the estrogen modulation of parathyroid hormone-stimulated cyclic amp accumulation in opossum kidney cells. J Cell Physiol 150: 517-525.
33. Han HJ, Lee YH, Park KM, Taub M (2002) Estradiol-17 stimulates phosphate uptake and is mitogenic for primary rabbit renal proximal tubule cells. Exp Nephrol 10: 355-364.
34. Cowell LN, Graham JD, Bouton AH, Clarke CL, O'Neill GM (2006) Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130cas/ bcar1, fak and src, via an adhesion-dependent pathway. Oncogene 25: 7597-7607.
35. Simoncini T, De Caterina R, Genazzani AR (1999) Selective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (vcam-1) expression in human endothelial cells. J Clin Endocrinol Metab 84: 815-818.
36. Erman M, Abali H, Oran B, Haznedaroglu IC, Canpinar H, et al. (2004) Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state? Ann Oncol 15: 1622-1626.
37. Semenza GL (2002) Hif-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8: 62-67.
38. Seo DM, Goldschmidt-Clermont PJ, West M (2007) Of mice and men: Sparse statistical modelling in cardiovascular genomics. Ann Appl Stat 1: 152-178.
39. Lucas JE, Carvalho C, Merl D, West M (2008) In-Vitro to In-Vivo Factor Profiling in Expression Genomics Taylor-Francis, In press.